“‘To Study The Association Of Leptin As A Predictive Marker In Obese And Non-Obese Women With Polycystic Ovary Syndrome Patients.’” (2022) Journal of Pharmaceutical Negative Results, pp. 3930–3940. doi:10.47750/pnr.2022.13.S08.495.